ATE450254T1 - Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase - Google Patents

Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase

Info

Publication number
ATE450254T1
ATE450254T1 AT00956599T AT00956599T ATE450254T1 AT E450254 T1 ATE450254 T1 AT E450254T1 AT 00956599 T AT00956599 T AT 00956599T AT 00956599 T AT00956599 T AT 00956599T AT E450254 T1 ATE450254 T1 AT E450254T1
Authority
AT
Austria
Prior art keywords
phase
pharmaceutical composition
inactive
floating
active
Prior art date
Application number
AT00956599T
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Galenix Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenix Dev filed Critical Galenix Dev
Application granted granted Critical
Publication of ATE450254T1 publication Critical patent/ATE450254T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT00956599T 1999-08-06 2000-08-02 Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase ATE450254T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910285A FR2797185B1 (fr) 1999-08-06 1999-08-06 Composition pharmaceutique flottante comprenant une phase active et une phase non active
PCT/FR2000/002223 WO2001010417A1 (fr) 1999-08-06 2000-08-02 Composition pharmaceutique flottante comprenant une phase active et une phase non active

Publications (1)

Publication Number Publication Date
ATE450254T1 true ATE450254T1 (de) 2009-12-15

Family

ID=9548990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956599T ATE450254T1 (de) 1999-08-06 2000-08-02 Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase

Country Status (12)

Country Link
US (1) US7682629B1 (de)
EP (1) EP1206247B1 (de)
AT (1) ATE450254T1 (de)
AU (1) AU779036B2 (de)
BR (1) BR0013106A (de)
CA (1) CA2378988C (de)
DE (1) DE60043442D1 (de)
FR (1) FR2797185B1 (de)
HU (1) HUP0202764A3 (de)
IL (2) IL148003A0 (de)
NO (1) NO20020572L (de)
WO (1) WO2001010417A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211317A (pt) 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
ATE369139T1 (de) * 2002-12-20 2007-08-15 Hoffmann La Roche Hochdosierte ibandronat-formulierung
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
EP1959923A4 (de) * 2005-08-30 2012-05-02 Piramal Life Sciences Ltd Pharmazeutische metforminzusammensetzung mit verlängerter freisetzung und herstellungsverfahren dafür
EP2191848A4 (de) * 2007-08-31 2013-05-15 Daiichi Sankyo Co Ltd Zubereitung mit verzögerter freisetzung und herstellungsverfahren dafür
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2967352B1 (fr) * 2010-11-12 2012-12-28 Unither Dev Comprime effervescent pour l'administration par voie orale de principes actifs
US10172794B2 (en) 2013-12-13 2019-01-08 Biogen Ma Inc. Controlled release dosage form for once daily administration of dimethyl fumarate
WO2019126215A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
JP2021506984A (ja) * 2017-12-18 2021-02-22 トリス・フアルマ・インコーポレーテツド トリガーパルス薬物放出を有する胃内滞留型ｒａｆｔ形成システムを含む放出調節薬物粉末組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
BR0013106A (pt) 2002-07-23
HUP0202764A2 (hu) 2003-01-28
CA2378988A1 (fr) 2001-02-15
DE60043442D1 (de) 2010-01-14
EP1206247A1 (de) 2002-05-22
US7682629B1 (en) 2010-03-23
AU6848700A (en) 2001-03-05
FR2797185A1 (fr) 2001-02-09
FR2797185B1 (fr) 2001-10-26
CA2378988C (fr) 2012-04-17
IL148003A (en) 2007-06-03
WO2001010417A1 (fr) 2001-02-15
EP1206247B1 (de) 2009-12-02
IL148003A0 (en) 2002-09-12
HUP0202764A3 (en) 2004-05-28
NO20020572D0 (no) 2002-02-05
NO20020572L (no) 2002-04-03
AU779036B2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
ID21259A (id) Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif
DE69019817D1 (de) Trägermaterial zur Arzneimittelverabreichung.
ATE450254T1 (de) Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69514087T2 (de) Pharmazeutisch aktive substituierte aromatische verbindungen
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
ATE357941T1 (de) Vorrichtungen zur medikamentverabreichung
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
DE69908399D1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
WO1999047101A3 (en) Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
DE50013950D1 (de) Arzneistoffträger zur kontrollierten wirkstoffapplikation hergestellt aus lipidmatrix-arzneistoff-konjugaten (lak-partikel)
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
DK524489D0 (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
IT8920405A0 (it) Aminoimidazopiridine farmacologicamente attive.
IT1307751B1 (it) Composizione di catalizzatore contenente fosfati per la preparazionedi poliesteri e procedimenti relativi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties